Printer Friendly

36 of the Most Promising Early-Stage Vascular Device Companies will be Featured at Medtech Insight's 'in circulation: Strategic Partnering and Investing in Circulatory Medicine' Conference in 3 Weeks.

NEWPORT BEACH, Calif. -- Medtech Insight, a division of Windhover Information Inc. and a leading provider of business information and analysis on the medical technology industry, has announced that its "in circulation: Strategic Partnering and Investing in Circulatory Medicine" conference on April 27, 2005, in Chicago, will feature presentations by 36 innovative emerging vascular technology companies, representing the newest and brightest the industry has to offer, seeking strategic partnerships, funding, and/or acquisition.

"in circulation," being held at the Hyatt Regency McCormick Place in Chicago, will be the first specialty-specific investment and partnering conference focusing on early-stage companies developing products for such high-growth segments as interventional cardiology, stroke, peripheral vascular disease, electrophysiology, congestive heart failure, cardiac surgery and cardiovascular disease and diagnosis, and regenerative medicine, among others. The conference will draw an attendance of over 250 of the top dealmakers from the investment community as well as major medical technology, biopharmaceutical, and biotech firms, seeking strategic partnering and investment opportunities in the double-digit-growth circulatory disease diagnosis and therapeutic market.

Among the early-stage companies confirmed to present at "in circulation" are: Allvivo Vascular, AzERx, CardiacAssist, Cardiac Output Technologies, Cardiac Power, Cardio3, CardioLa, CHF Technologies, CoAxia, CoolTouch, Direct Flow Medical, Endothelix, HeartSTAT, Hemonix, IDev Technologies, Inovise Medical, Integrated Sensing Systems, Minnow Medical, MiTiHeart, Mitralign, MitralSolutions, Myocor, National Quality Care, Neural Intervention Technologies, NMT Medical, NovoSci, Odicrain, OmniSonics Medical Technologies, Orqis Medical, Percardia, PlaCor, QuantumCor, Transvivo, Vascular Reconditioning, and Vital Sensors (check the Medtech Insight Web site at for regularly updated event information). The event is arranged in a single-track format, consisting of 10-minute company presentations immediately followed by individual meetings in private breakout rooms.

The "in circulation" audience will include senior management from these top-tier medical technology companies and investment firms, among many others: Abbott Laboratories, Adams Harkness, Advanced Technology Ventures, Affinity Capital Management, Arrow International, Ascension Health Ventures, Baird Venture Partners, Baxter Healthcare, Boston Scientific, Cardinal Health, Cook, Cordis, Datascope, De Novo Ventures, Edwards Lifesciences, Fresenius Medical Care, Guidant, Johnson & Johnson, Kensey Nash, KeyBanc Capital Markets, Kimberly-Clark, Mallinckrodt Medical, Medtronic, Musculoskeletal Transplant Foundation, Philips Medical Systems, Regeneration Technologies, Roberts Mitani, Roche Diagnostics, Spray Venture Partners, St. Jude Medical, and Volant Ventures, and many more.

The program will be kicked off by a keynote presentation by cardiac device entrepreneur Manny Villafana, chairman and CEO of CABG Medical Inc., a startup company developing an artificial coronary artery graft. Villafana, who will speak on the "Trials and Tribulations of a Biomedical Device Entrepreneur," is bringing over 40 years of medical device industry and product development experience to the "in circulation" stage, including founding the successful companies Cardiac Pacemakers/Guidant, St. Jude Medical, GV Medical, and ATS Medical. He is also co-developer of the St. Jude heart valve, and co-inventor of the first open pivot heart valve from ATS Medical.

"in circulation" will also feature a timely, interactive panel discussion titled "Turf Wars: Who Will Take Hold of New Technologies?" The session will feature a group of industry expert interventionalist and surgeon panelists, led by the leading cardiovascular clinicians/event co-chairs Michael J. Mack, M.D., chairman, board of directors at The Cardiopulmonary Research Science & Technology Institute and director of Cardiovascular Services, director of transplantation at Medical City Dallas Hospital; and Richard Heuser, M.D., director of cardiovascular research at St. Joseph's Hospital & Medical Center, and clinical professor of medicine at University of Arizona, College of Medicine. The panel will be moderated by David Cassak, managing partner at Windhover Information.

Event co-sponsors include Boston Biomedical Associates, Business Wire, Medmarc and The Hartford, Ronald Trahan Associates, The Medtech Group, and Windhover Information.

Don't miss this opportunity of the year to partner, invest and network with the industry decision-makers driving the development of advanced circulatory medicine technologies. To register, call Kristy Grimes of Medtech Insight at 480-985-9512, e-mail, or register on the Medtech Insight Web site, at

About Medtech Insight

Medtech Insight, a division of Windhover Information Inc., is the leading provider of business information and market intelligence for the medical technology marketplace. For more on the company's products and services, please visit
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Apr 6, 2005
Previous Article:Blue Cross of California Introduces New Affordable Health Plan for Seniors in Tulare County.
Next Article:Spirit Airlines Reports Record March 2005 Traffic; Load Factor Reaches 86.5%.

Related Articles
Medtech Insight's 'in circulation' Partnering and Investment Meeting to Feature Prominent Cardiac Device Entrepreneur Manny Villafana as Keynote...
Medtech Insight's Upcoming 'in circulation' Partnering and Investment Meeting to Feature Presentations by over 30 Innovative Privately Held...
More Than 20 Emerging Privately Held Cardiovascular and Interventional Cardiology Companies Already Confirmed to Present at Medtech Insight's ''in...
Medtech Insight Announces ``Investment In Innovation: A Preview of Early-Stage Medical Technology Companies'' Investment and Partnering Conference,...
Medtech Insight's 'in circulation' Partnering and Investment Meeting Featuring Presentations by More Than 35 Early-Stage Cardiovascular and...
Medtech Insight Will Hold its First In3 EUROPE Early-Stage Medical Technology Investment and Partnering Conference on Sept. 20-21 in Brussels,...
Boston Biomedical Associates -BBA- To Co-Sponsor Medtech Insight's ''In Circulation'' Conference.
Boston Biomedical Associates to Co-Sponsor Medtech Insight's ``In Circulation'' Conference.
Medtech Insight's ''in circulation'' Investment and Partnering Conference to Feature Presentations by Over 35 Emerging Cardiovascular Technology...
Vascular Reconditioning, Inc. to Present at Medtech Insight's ``In Circulation'' Conference.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters